Source: Aurora Spine Corporation.
  • Aurora Spine Corporation (ASG) has announced a C$6.5 million private placement with institutional investors
  • 11,220,930 units will be issued at a price of $0.58 per common share and associated common warrant
  • It expects the closing date to occur on or about September 17, 2021
  • Aurora Spine Corporation brings new solutions to the spinal implant market through minimally invasive regenerative spinal implant technologies
  • Aurora Spine Corporation (ASG) closed down by 10.94 per cent trading at $0.57 per share

Aurora Spine Corporation (ASG) has announced a C$6.5 million private placement with institutional investors.

It will issue up to 11,220,930 units priced at $0.58 per common share and associated common warrant.

Each warrant entitles the holder to purchase one common share for $0.75 for up to three years after the closing of the offering.

Aurora expects the closing date to occur on or about September 17, 2021.

Aurora will offer shares and warrants in the United States on a private placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933.

No securities will be sold or offered for sale in Canada.

Aurora Spine Corporation brings new solutions to the spinal implant market through minimally invasive regenerative spinal implant technologies.

Aurora Spine Corporation (ASG) closed down by 10.94 per cent trading at $0.57.

More From The Market Online

EU authorizes new COVID vaccine from Pfizer and BioNTech

The EU grants marketing authorization to Pfizer and BioNTech's COVID-19 vaccine targeting the new XFG variant.

PharmaTher evaluating 3D printing for personalized peptide medicines

PharmaTher is out to evaluate its GMP-ready 3D printing platform for producing personalized peptide medicines with customized doses.

Why biotech is outpacing the AI slump: 3 stocks to watch

The biotech sector is outperforming the broader market, shining a light on stocks best-positioned to address unmet patient needs.

The 5-Minute Investor Podcast, Ep. 71: Weight-loss drug stocks

Listen to ep. 71 of The 5-Minute Investor Podcast, with analysis on weight-loss drug stocks Structure Therapeutics and Viking Therapeutics.